The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Urolithiasis and the Risk of ESRD
Open accessAbstract
Summary: Background and objectives: The contribution of urolithiasis, if any, to the development of ESRD is unclear. Design, setting, participants, & measurements: All stone formers in Olmsted County, Minnesota, first diagnosed between 1984 and 2008 were identified by diagnostic codes with up to four controls matched on age and sex. Charts were reviewed to validate symptomatic stone formers in a random subset. Incident ESRD events were identified by the US Renal Data System. Results: Altogether, 51 stone formers and 75 controls developed ESRD among 6926 stone formers and 24,620 matched controls followed for a mean of 9 years. Stone formers had an increased risk of ESRD after adjusting for diabetes, hypertension, dyslipidemia, gout, and CKD (hazard ratio: 2.09; 95% confidence interval: 1.45–3.01). This increased risk of ESRD remained in the subset of 2457 validated symptomatic stone formers (hazard ratio: 1.95; 95% confidence interval: 1.09–3.49). The attributable risk of ESRD from symptomatic urolithiasis was 5.1% based on a prevalence of 5.4% for stone formers. For stone formers versus controls who developed ESRD, there was an increased likelihood of past hydronephrosis (44% versus 4%), recurrent urinary tract infections (26% versus 4%), acquired single kidney (15% versus 3%), neurogenic bladder (12% versus 1%), and ileal conduit (9% versus 0%), but not diabetes (32% versus 49%) or hypertension (44% versus 52%). Conclusions: Symptomatic stone formers are at increased risk for ESRD independent of several cardiovascular risk factors. Other urological disease is relatively common among stone formers who develop ESRD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
History of the Rochester Epidemiology Project
Melton, L. J. (1996) · Mayo Clinic Proceedings · doi:10.4065/71.3.266 · Cited by 1,443
Self-citation
Cited by
Khan, S. R., Pearle, M. S., Robertson, W. G., Gambaro, G., Canales, B. K., Doizi, S., Traxer, O., & Tiselius, H.-G. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.8 · Cited by 1,097
Kidney Stone Disease: An Update on Current Concepts
Alelign, T., & Petros, B. (2018) · Advances in Urology · doi:10.1155/2018/3068365 · Cited by 852
Prevalence of kidney stones in China: an ultrasonography based cross‐sectional study
Zeng, G., Mai, Z., Xia, S., Wang, Z., Zhang, K., Wang, L., Long, Y., Ma, J., Li, Y., Wan, S. P., et al. (2017) · BJU International · doi:10.1111/bju.13828 · Cited by 522
The ROKS Nomogram for Predicting a Second Symptomatic Stone Episode
Rule, A. D., Lieske, J. C., Li, X., Melton, L. J., Krambeck, A. E., & Bergstralh, E. J. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013091011 · Cited by 297
Self-citationTrends in the prevalence of kidney stones in the United States from 2007 to 2016
Chewcharat, A., & Curhan, G. (2021) · Urolithiasis · doi:10.1007/s00240-020-01210-w · Cited by 276
Metadata
- Authors
- El-Zoghby, Z. M., Lieske, J. C., Foley, R. N., Bergstralh, E. J., Li, X., Melton, L. J., Krambeck, A. E., & Rule, A. D.
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2012-09
- Volume
- 7
- Issue
- 9
- Pages
- 1409-1415
- ISSN
- 1555-9041 (ISSN-L)
- OpenAlex
- W2112341317
- Cited by
- 176
- References
- 1
- FWCI
- 3.79
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Urolithiasis and the Risk of ESRD. https://app.cochat.ai/papers/10.2215/cjn.03210312
- The paper
- El-Zoghby, Z. M., Lieske, J. C., Foley, R. N., Bergstralh, E. J., Li, X., Melton, L. J., Krambeck, A. E., & Rule, A. D. (2012). Urolithiasis and the Risk of ESRD. Clinical Journal of the American Society of Nephrology. https://doi.org/10.2215/cjn.03210312
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.